Posted by Surbhi on July 24 2026 at 05:41 PM
public
Setmelanotide (IMCIVREE) — the first FDA-approved melanocortin-4 receptor (MC4R) agonist specifically indicated for proopiomelanocortin (POMC) deficiency-associated obesity representing the targe...
Posted by Surbhi on July 02 2026 at 05:36 PM
public
Proopiomelanocortin deficiency — the ultra-rare monogenic obesity disorder caused by loss-of-function mutations in the POMC gene resulting in early-onset severe obesity, hyperphagia, adrenal insu...
Growth Hormone Deficiency (GHD) clinical management is undergoing a significant transition from a stressful, high-frequency treatment model to a patient-friendly, long-acting therapeutic standard...
"Executive Summary Glucose 6-Phosphate Dehydrogenase Deficiency Market :
CAGR Value
Glucose 6-phosphate dehydrogenase deficiency market is expected to gain market growth in the forecast period ...
